United States HR 4712: Fairness in Orphan Drug Exclusivity Act

Status: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (as of 2020-11-18)

State: United States · Session: 116 · Bill: HR 4712

Subjects: Competition and antitrust, Drug safety, medical device, and laboratory regulation, Licensing and registrations, Marketing and advertising, Prescription drugs

Sponsors: Madeleine Dean, Andy Kim, Darren Soto, David B. McKinley, Earl L. "Buddy" Carter, Marc A. Veasey, Paul Tonko, Van Taylor

View United States HR 4712 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.